A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients
NCT03099876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320
Last updated 2017-04-07
Summary
This study compared efficacy and safety of basic triple therapy according to treatment period. This study evaluated Effect of CYP2C19 genetic polymorphisms on the efficacy
Conditions
- Helicobacter Pylori Infection
Interventions
- PROCEDURE
-
treatment period
7 days treatment or 10 days treatment
Sponsors & Collaborators
-
Il-Yang Pharm. Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2017-12-01
- Completion
- 2018-12-01
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy
NCT00669955 ·Status: COMPLETED ·Phase: PHASE3
-
H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy
NCT05002595 ·Status: COMPLETED
-
RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
NCT02092506 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
NCT03139253 ·Status: UNKNOWN ·Phase: PHASE4
-
Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
NCT00149084 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
NCT06751121 ·Status: COMPLETED ·Phase: PHASE3
-
Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
NCT04090021 ·Status: UNKNOWN ·Phase: PHASE4
-
Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
NCT01906879 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection
NCT05419674 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Triple Therapy With CJ-12420 in H. Pylori Positive Patients
NCT03317223 ·Status: COMPLETED ·Phase: PHASE3
-
Molecular Detection of Antibiotic Resistance and H Pylori Eradication
NCT01168063 ·Status: COMPLETED ·Phase: NA
-
Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
NCT01769365 ·Status: COMPLETED ·Phase: PHASE4
-
The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
NCT02648659 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
NCT05742568 ·Status: COMPLETED ·Phase: PHASE4
-
Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori Infection
NCT03516669 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
NCT02873065 ·Status: COMPLETED ·Phase: PHASE4
-
Tailored Therapy for Clarithromycin-Resistant H. Pylori
NCT03431688 ·Status: COMPLETED ·Phase: NA
-
Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori
NCT02776371 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori
NCT01573975 ·Status: COMPLETED ·Phase: PHASE4
-
Eradication Rates of Helicobacter Pylori and Its Affecting Factors
NCT01922505 ·Status: COMPLETED
-
Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy
NCT02487511 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection
NCT03361267 ·Status: UNKNOWN ·Phase: NA
-
Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication
NCT01306786 ·Status: COMPLETED ·Phase: NA
-
A Unique Regimen for Treatment of Helicobacter Pylori Infection
NCT03491995 ·Status: UNKNOWN ·Phase: PHASE3
-
High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)
NCT07121205 ·Status: COMPLETED